STAT5d
Q&A: How the FDA is approaching AI in clinical trials and drug development
The FDA's Tala Fakhouri discusses the agency's approach to the regulation of AI in clinical trials in a new interview.
The Tribune-Democrat3dOpinion
Andrei Iancu and David Kappos | Proposed drug patent reforms would do more harm than good
Congress is considering a bill that could exacerbate government waste and give American companies’ most valuable trade ...
Money Talks News on MSN3h
Groceries and Fast Food Are Widely Tainted With a Rocket Fuel Chemical, Testing Finds
We do our best to take care of ourselves, but recent testing shows there’s a potentially harmful chemical that even our fresh ...
FDA approves first once-weekly drug treatment regimen for hemophilia
Patients suffering from hemophilia received a "meaningful" advancement on Friday when federal regulators approved the first ...
STAT2d
In stark reversal, FDA to reconsider removal of Eli Lilly weight loss drug from shortage list
The FDA, in a stark reversal, on Friday said it would reconsider its decision to remove Eli Lilly’s tirzepatide from its ...
policymed.com11h
Mirati Therapeutics Receives Untitled Letter from OPDP for Overstating Cancer Drug Efficacy
Office of Prescription Drug Promotion (OPDP) recently sent an untitled letter to Mirati Therapeutics for claims made by the ...
The FDA Just Recalled Nearly 10 Million Pounds of Ready-to-Eat Meat and Poultry Nationwide
According to the FDA announcement, the recall includes approximately 9,986,245 pounds of ready-to-eat meat and poultry ...
PipelineReview.com5d
U.S. Food and Drug Administration (FDA) accepts New Drug Application for elinzanetant
BERLIN, Germany I October 09, 2024 I Bayer today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s New Drug Application ...